Research Articles | Page 79 | Aplastic Anemia & MDS International Foundation Return to top.
  1. Articles
  2. Research Articles

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Quality of life and physicians' perception in myelodysplastic syndromes May 2012 Am J Blood Res myelodysplastic syndromes (MDS)
Question prompt list responds to information needs of myelodysplastic syndromes patients and caregivers Jun 2015 Leuk Res myelodysplastic syndromes (MDS)
Rabbit antithymocyte globulin and cyclosporine as first-line therapy for children with acquired aplastic anemia Jan 2013 Blood aplastic anemia
Rabbit Antithymocyte Globulin Treatment in Childhood Acquired Severe Aplastic Anemia. Apr 2013 Pediatr Hematol Oncol aplastic anemia
Rabbit antithymocyte globulin versus horse antithymocyte globulin for treatment of acquired aplastic anemia: a retrospective analysis Feb 2015 Ann Hematol aplastic anemia
Rabbit-antithymocyte globulin combined with cyclosporin A as a first-line therapy: improved, effective, and safe for children with acquired severe aplastic anemia. Mar 2012 J Cancer Res Clin Oncol aplastic anemia
Radiation alone for solid tumors and the questionable development of therapy-related myelodysplastic syndromes Mar 2014 J Natl Cancer Inst myelodysplastic syndromes (MDS)
Raising the bar for lower-risk myelodysplastic syndromes Apr 2023 Leukemia & Lymphoma myelodysplastic syndromes (MDS)
Randomized Open-Label Phase II Study of Decitabine in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes. Jun 2013 J Clin Oncol myelodysplastic syndromes (MDS)
Randomized Phase II Study of Azacitidine Alone or in Combination With Lenalidomide or With Vorinostat in Higher-Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia: North American Intergroup Study SWOG S1117 May 2017 J Clin Oncol myelodysplastic syndromes (MDS)
Share with addtoany.com.